Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Filing Details

Accession Number:
0001127602-12-035190
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-12-28 16:33:37
Reporting Period:
2012-12-27
Filing Date:
2012-12-28
Accepted Time:
2012-12-28 16:33:37
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1082554 United Therapeutics Corp UTHR Pharmaceutical Preparations (2834) 521984749
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1106578 A Martine Rothblatt C/o United Therapeutics Corporation
1040 Spring Street
Silver Spring MD 20910
Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2012-12-27 3,000 $52.41 708,602 No 4 P Indirect By Trusts
Common Stock Acquisiton 2012-12-28 1,167 $52.38 709,769 No 4 P Indirect By Trusts
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect By Trusts
No 4 P Indirect By Trusts
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 0 Direct
Footnotes
  1. Shares were purchased pursuant to pre-arranged 10b5-1 trading plans entered into by trusts beneficially owned by the reporting person and the reporting person's spouse.
  2. This transaction was executed in multiple trades at prices ranging from $52.22 to $52.77. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  3. Shares held by the reporting person in GRATs and PMTs.
  4. This transaction was executed in multiple trades at prices ranging from $52.23 to $52.44. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.